PubMed دسترسی آزاد

Ecopharmacovigilance and Drug Disposal: A Survey of Knowledge, Attitudes and Practices Among Veterinary Healthcare Providers in and Around Gondar City, Ethiopia.

استودیوی صوتی مقاله

پخش حرفه‌ای فارسی و انگلیسی

در حال بررسی نسخه‌های صوتی ذخیره‌شده…

صوت تولیدشده با هوش مصنوعی است. برای کاربرد علمی یا درمانی، متن و منبع اصلی را بررسی کنید.
خواندن هوشمند فارسی و انگلیسی در حال آماده‌سازی صداهای مرورگر…
تنظیم صدای طبیعی و سرعت

صداهایی که در نامشان «Natural»، «Neural» یا «Online» دیده می‌شود معمولاً طبیعی‌ترند. انتخاب صدا به صداهای نصب‌شده در ویندوز و مرورگر شما بستگی دارد.

چکیده اصلی

BACKGROUND: Veterinary pharmaceuticals often enter into ecosystems through the disposal of unused and expired medicines and animal excreta. Consequently, these substances are emerging as a global threat, posing risks to ecosystems, biodiversity and public health. However, despite the increasing concerns attributed to veterinary pharmaceuticals, there is a lack of empirical data regarding awareness and practices related to ecopharmacovigilance (EPV) among veterinary professionals in Ethiopia. EPV is an emerging discipline focused on the detection, evaluation, understanding and the prevention of the environmental impacts of pharmaceuticals. This knowledge gap highlights the need for evidence-based assessment of veterinary professionals' awareness and practices of EPV in Ethiopia. Therefore, this study aimed to assess veterinary professionals' knowledge, attitudes and practices (KAP) regarding EPV and pharmaceutical waste management. METHODS: A cross-sectional survey was conducted between January 2024 and May 2025 among 37 veterinary healthcare providers in and around Gondar City. The data were collected using a structured, self-administered questionnaire. Data were analysed using SPSS version 25 through descriptive statistics and chi-square tests to identify associations between socio-demographic characteristics and KAP indicators. RESULTS: The study found that 73% of respondents had never heard of EPV, 78.4% had not received relevant training, and 67.6% reported the absence of pharmaceutical disposal guidelines in their facilities. Although 94.6% acknowledged the harmful effects of improper drug disposal on human and environmental health, only 16.2% were familiar with the term EPV. Knowledge was marginally associated with reading scientific literature (p = 0.084), whereas attitudes were significantly related to prior knowledge (p = 0.001), training (p = 0.001) and reviewing related reports (p = 0.001). Practices were influenced by prior knowledge (p = 0.023) and engagement with literature (p = 0.032). About 40.5% of participants disposed of pharmaceuticals in regular trash, and only 27% returned unused drugs to appropriate authorities. Overall, 62.8% of respondent's demonstrated poor knowledge, 56.8% held negative attitudes, and practices were inadequate. CONCLUSION: This baseline study reveals low awareness of EPV and poor waste management practices among veterinary healthcare providers. The study shows the urgent need for targeted training, policy enforcement and the integration of environmental education into veterinary curricula in Ethiopia. This is necessary to promote responsible pharmaceutical stewardship and safeguard the environment and public health.

متن کامل اصلی

نسخه دارای مجوز در منبع علمی در دسترس است.

لینک مستقیم از metadata منبع گرفته شده و در تب جدید باز می‌شود.

باز کردن متن کامل

کلیدواژه‌ها

Central Gondar ZoneEthiopiadrug disposalecopharmacovigilanceenvironmental riskguidelines pharmaceutical wasteveterinary professionals
در همین زیرشاخه

مقاله‌های مرتبط

PubMed2026

Flibanserin safety in real-world use: a decade of US Food and Drug Administration Adverse Event Reporting System pharmacovigilance evidence.

BACKGROUND: Flibanserin, a centrally acting 5-HT1A agonist and 5-HT2A antagonist, is the first approved therapy for acquired, generalized hypoactive sexual desire disorder in premenopausal women. Despite its clinical availability, post-marketing data on real-world safety remain limited. METHODS: A retrospective pharmacovigilance analysis was conducted using the US Food and Drug Administration Adverse Event Reporting System from 2016 to…

PubMed2026

Risk of Major Malformations Following First-Trimester Exposure to Cariprazine: Preliminary Data From the MGH National Pregnancy Registry for Psychiatric Medications.

OBJECTIVE: Systematically collected pregnancy safety data for cariprazine have been lacking, despite growing use of this medication across psychiatric indications. The goal of this analysis was to determine the risk of major malformations among infants of mothers with psychiatric illness who used cariprazine during the first trimester of pregnancy compared to unexposed controls. METHODS: The National Pregnancy Registry for Psychiatric …

PubMed2026

Using Pharmacovigilance Data for Signal Detection of Drug Interactions for Rosuvastatin.

The 3-hydroxy-3-methyl-glutaryl-coenzyme A reductase inhibitor rosuvastatin is a substrate of breast cancer resistance protein (BCRP). BCRP inhibition increases rosuvastatin plasma concentrations and may result in concentration-dependent muscle toxicity, at worst rhabdomyolysis. We investigated if concomitant use of rosuvastatin and drugs identified as in vitro BCRP inhibitors shows an increased number of rhabdomyolysis events based on…

PubMed2026

Assessing the risk of cataracts associated with medications: A pharmacovigilance analysis of the FAERS database.

Cataracts are a leading cause of global blindness and visual impairment, with drug-induced cataracts emerging as a significant yet understudied contributor. This study aimed to comprehensively and systematically investigate medication-related cataract risk signals using data from the FDA Adverse Event Reporting System. We searched the FDA Adverse Event Reporting System database for all reported cases of medication-related cataracts fro…